The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Sri Lanka:outcome of the BOLD study

Amarasiri, Lakmali; Gunasinghe, Wathsala; Sadikeen, Aflah; Fernando, Amitha; Madegedara, Dushantha; Wickramasinghe, Rajitha; Gunasekera, Kirthi

doi:10.1183/1393003.congress-2017.pa1212

Cited by 10 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Further, more than 90% of COPD deaths occur in low-income and middle-income countries. 2 The most recent estimate of COPD prevalence in South Asia was 6.3% 3 with a prevalence in Sri Lanka of 10.5%, 4 similar to the estimated global COPD prevalence of Strengths and limitations of this study ► This study is the first examining the feasibility and acceptability of a culturally appropriate pulmonary rehabilitation programme for adults with chronic obstructive pulmonary disease in Sri Lanka. ► Taking a mixed-method approach, this study will provide a rich insight into delivering a trial of pulmonary rehabilitation in the Sri Lankan context.…”

Section: Introductionsupporting

confidence: 59%

See 1 more Smart Citation

Protocol for the cultural adaptation of pulmonary rehabilitation and subsequent testing in a randomised controlled feasibility trial for adults with chronic obstructive pulmonary disease in Sri Lanka

et al. 2020

Self Cite

View full text Add to dashboard Cite

IntroductionInternational guidelines recommend pulmonary rehabilitation (PR) should be offered to adults living with chronic obstructive pulmonary disease (COPD), but PR availability is limited in Sri Lanka. Culturally appropriate PR needs to be designed and implemented in Sri Lanka. The study aims to adapt PR to the Sri Lankan context and determine the feasibility of conducting a future trial of the adapted PR in Sri Lanka.Methods and analysisEligible participants will be identified and will be invited to take part in the randomised controlled feasibility trial, which will be conducted in Central Chest Clinic, Colombo, Sri Lanka. A total of 50 participants will be recruited (anticipated from April 2021) to the trial and randomised (1:1) into one of two groups; control group receiving usual care or the intervention group receiving adapted PR. The trial intervention is a Sri Lankan-specific PR programme, which will consist of 12 sessions of exercise and health education, delivered over 6 weeks. Focus groups with adults living with COPD, caregivers and nurses and in-depth interviews with doctors and physiotherapist will be conducted to inform the Sri Lankan specific PR adaptations. After completion of PR, routine measures in both groups will be assessed by a blinded assessor. The primary outcome measure is feasibility, including assessing eligibility, uptake and completion. Qualitative evaluation of the trial using focus groups with participants and in-depth interviews with PR deliverers will be conducted to further determine feasibility and acceptability of PR, as well as the ability to run a larger future trial.Ethics and disseminationEthical approval was obtained from the ethics review committee of Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka and University of Leicester, UK. The results of the trial will be disseminated through patient and public involvement events, local and international conference proceedings, and peer-reviewed journals.Trial registration numberISRCTN13367735

show abstract

Section: Introductionsupporting

confidence: 59%

Section: Introductionmentioning

confidence: 64%

Protocol for the cultural adaptation of pulmonary rehabilitation and subsequent testing in a randomised controlled feasibility trial for adults with chronic obstructive pulmonary disease in Sri Lanka

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Out of four main non communicable diseases, COPD adversely impact the health status of the Sri Lankan population [3]. Sri Lanka has shown an overall prevalence of 10.5% of COPD patients, where the urban and rural prevalence rates are 6.4% and 4.1% correspondingly [4]. COPD causes a significant economic burden to the country.…”

Section: Introductionmentioning

confidence: 99%

The Influence of Disease Severity on Health Related Quality of Life of Patients with COPD

Fernando¹,

Wickramanayake²,

Dulanjanie³

et al. 2021

IJRP

View full text Add to dashboard Cite

Chronic Obstructive Pulmonary Disease (COPD) is one of the major global health issues becoming of the leading cause of morbidity and mortality around the world. This study was undertaken to evaluate the impact of disease severity on Health Related Quality of Life (HRQoL) and the influence of factors affecting on it.A total of 77 patients who had been medically diagnosed as COPD by a consultant physician were recruited according to systematic sampling method at National Hospital for Respiratory Diseases, Welisara. St. George's Respiratory Questionnaire was used to assess HRQoL and lung function parameters and socio demographic data was collected. Disease severity of COPD patients was categorized according to GOLD guidelines. Data was analyzed using SPSS version 23.0.The mean age of 77 participants was 59.39±7.28 ranged from 40-70 years and majority of them were males (n=70, 90.9%). Patients fallen under GOLD stage I was not observed within the sample. There was no statistically significant difference in the SGRQ scores between the severity groups (p = 0.347). Significant weak negative correlations were found between impact domain and FEV1 (r =-0.239, p = 0.036) and FEV1 predicted % (r = -0.223, p = 0.049). Further significant negative correlation was found between FEV1 predicted % and symptom domain (r = -0.202 p=0.039)The influence of disease severity on HRQoL can be vary once the disease has progressed in COPD patient regardless of gender, age, and smoking habits. The impact of comorbidities should be observed to identify the influence of them on HRQoL.

show abstract

“…The disease burden due to asthma and COPD is higher in South Asian countries, due to higher rates of these illnesses (3). The burden of lung disease survey reported a 10.5% prevalence of COPD in Sri Lanka, while the world health survey reported a 5.3% prevalence of asthma (4,5).…”

Section: Original Paper Backgroundmentioning

confidence: 99%

Anxiety and depression among patients at a tertiary care respiratory clinic in Sri Lanka

et al. 2018

View full text Add to dashboard Cite

show abstract

The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Sri Lanka:outcome of the BOLD study

Cited by 10 publications

References 0 publications

Protocol for the cultural adaptation of pulmonary rehabilitation and subsequent testing in a randomised controlled feasibility trial for adults with chronic obstructive pulmonary disease in Sri Lanka

Protocol for the cultural adaptation of pulmonary rehabilitation and subsequent testing in a randomised controlled feasibility trial for adults with chronic obstructive pulmonary disease in Sri Lanka

The Influence of Disease Severity on Health Related Quality of Life of Patients with COPD

Anxiety and depression among patients at a tertiary care respiratory clinic in Sri Lanka

Contact Info

Product

Resources

About